Neutropenia and pancytopenia associated with oral terbinafine.
Kovacs
M J
MJ
Department of Hematology, Victoria Hospital, London, Ontario, Canada.
Alshammari
S
S
Guenther
L
L
Bourcier
M
M
D000284:Administration, Oral; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects*; D009503:Neutropenia / Q000139:chemically induced*; D014009:Onychomycosis / Q000188:drug therapy; D010198:Pancytopenia / Q000139:chemically induced*; D000077291:Terbinafine; D014008:Tinea Pedis / Q000188:drug therapy
D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine